A young British woman has become one of the first cancer patients to be injected with a new vaccine designed to stimulate the immune system so that it destroys tumours wherever they have spread in the body.
Kelly Potter, 35, was diagnosed with advanced cervical cancer in July 2015 and was among the first to be enrolled on a cancer vaccine trial that will run over the next two years involving up to 30 volunteers.
Medical researchers have designed the vaccine to encourage the immune system to react against a part of the cancer cell that allows it to continuously replicate without ever dying.
At the same time, the patients on the trial will be prescribed a chemotherapy drug that should, at low doses, “lift the brakes” on the immune system so that it is no longer prevented from attacking the body’s own cancer cells, scientists said.
Ms Kelly, who lives in Beckenham, Kent, was diagnosed with stage four cervical cancer and was eligible for the trial at Guy’s Hospital in London because the disease has unfortunately spread to other sites in her body.
“Although I had excellent treatment at Guy’s where the cancer was stabilised, it had already spread to spots on my liver and lungs. So when I was told that I may be eligible for this trial, I was delighted,” Ms Potter said.
http://www.independent.co.uk/news/science/british-woman-becomes-one-of-the-first-cancer-patients-to-be-injected-with-new-tumour-destroying-a6905506.html
Kelly Potter, 35, was diagnosed with advanced cervical cancer in July 2015 and was among the first to be enrolled on a cancer vaccine trial that will run over the next two years involving up to 30 volunteers.
Medical researchers have designed the vaccine to encourage the immune system to react against a part of the cancer cell that allows it to continuously replicate without ever dying.
At the same time, the patients on the trial will be prescribed a chemotherapy drug that should, at low doses, “lift the brakes” on the immune system so that it is no longer prevented from attacking the body’s own cancer cells, scientists said.
Ms Kelly, who lives in Beckenham, Kent, was diagnosed with stage four cervical cancer and was eligible for the trial at Guy’s Hospital in London because the disease has unfortunately spread to other sites in her body.
“Although I had excellent treatment at Guy’s where the cancer was stabilised, it had already spread to spots on my liver and lungs. So when I was told that I may be eligible for this trial, I was delighted,” Ms Potter said.
http://www.independent.co.uk/news/science/british-woman-becomes-one-of-the-first-cancer-patients-to-be-injected-with-new-tumour-destroying-a6905506.html